基础治疗联合电针老十针’治疗脓毒症胃肠功能障碍临床研究方案

注册号:

Registration number:

ITMCTR2024000428

最近更新日期:

Date of Last Refreshed on:

2024-09-12

注册时间:

Date of Registration:

2024-09-12

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

基础治疗联合电针老十针’治疗脓毒症胃肠功能障碍临床研究方案

Public title:

Basic treatment combined with electroacupuncture Lao Shi Zhen clinical research protocol for the treatment of sepsis and gastrointestinal dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基础治疗联合电针老十针’治疗脓毒症胃肠功能障碍临床研究方案

Scientific title:

Basic treatment combined with electroacupuncture Lao Shi Zhen clinical research protocol for the treatment of sepsis and gastrointestinal dysfunction

研究课题的正式科学名称简写:

Li

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李欣橦

研究负责人:

刘清泉

Applicant:

Xintong Li

Study leader:

Qingquan Liu

申请注册联系人电话:

Applicant telephone:

13820987299

研究负责人电话:

Study leader's telephone:

13910055687

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

laurencemm@163.com

研究负责人电子邮件:

Study leader's E-mail:

liuqingquan_2003@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市东城区美术馆后街23号

研究负责人通讯地址:

北京市东城区美术馆后街23号

Applicant address:

23 Meishuguan Backstreet Dongcheng District Beijing China.

Study leader's address:

23 Meishuguan Backstreet Dongcheng District Beijing China.

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京中医医院

Applicant's institution:

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2024BL02-078-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

首都医科大学附属北京中医医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Beijing Hospital of Traditional Chinese Medicine Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024/8/9 0:00:00

伦理委员会联系人:

刘声

Contact Name of the ethic committee:

Sheng Liu

伦理委员会联系地址:

北京市东城区美术馆后街23号

Contact Address of the ethic committee:

23 Meishuguan Backstreet Dongcheng District Beijing China.

伦理委员会联系人电话:

Contact phone of the ethic committee:

010-87906734

伦理委员会联系人邮箱:

Contact email of the ethic committee:

liusheng4377@163.com

研究实施负责(组长)单位:

首都医科大学附属北京中医医院

Primary sponsor:

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

研究实施负责(组长)单位地址:

北京市东城区美术馆后街23号

Primary sponsor's address:

23 Meishuguan Backstreet Dongcheng District Beijing China.

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京中医医院

具体地址:

北京市东城区美术馆后街23号

Institution
hospital:

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

Address:

23 Meishuguan Backstreet Dongcheng District Beijing China.

经费或物资来源:

国家中医药管理局高水平中医药重点学科建设项目

Source(s) of funding:

The State Administration of Traditional Chinese Medicine has built a high-level key discipline of traditional Chinese medicine

研究疾病:

脓毒症

研究疾病代码:

Target disease:

Sepsis

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

评价在西医治疗基础上加用电针”老十针“对脓毒症胃肠功能障碍的治疗作用。

Objectives of Study:

To evaluate the therapeutic effect of adding electroacupuncture "Lao Shi Zhen" on the basis of medicine treatment on the treatment of gastrointestinal dysfunction in sepsis.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合脓毒症诊断标准 (2)符合急性胃肠损伤分级Ⅰ级到Ⅲ级 (3)年龄≥18岁,性别不限 (4)患者或家属知晓研究内容,同意针灸治疗,并自愿签署知情同意书。

Inclusion criteria

(1) Meet the diagnostic criteria for sepsis (2) Meet the acute gastrointestinal injury classification level I to III (3) Age≥ 18 years old gender is not limited (4) The patient or family member knows the content of the study agrees to the acupuncture treatment and voluntarily signs the informed consent form.

排除标准:

(1)有原发胃肠道疾病者,如:消化道出血,胃溃疡,胃癌 (2)妊娠或准备妊娠者,或不能采取有效措施避孕者; (3)严重的精神疾患者; (4)因基础疾病导致患者预期生存时间少于28天,如恶性肿瘤控制不佳,既往30天内发生心跳骤停等; (5)确诊或高度疑似急性传染性疾病,如病毒性肝炎活动期、活动期肺结核等; (6)针刺穴位所在位置皮肤破损或感染者; (7)近3个月内参加过临床干预试验; (8)主治医生认为不宜参加本试验的受试者。

Exclusion criteria:

(1) Patients with primary gastrointestinal diseases such as: gastrointestinal bleeding gastric ulcer gastric cancer (2) Those who are pregnant or preparing to become pregnant or those who cannot take effective measures to prevent pregnancy; (3) Patients with severe mental illness; (4) The expected survival time of patients due to underlying diseases is less than 28 days such as poor control of malignant tumors cardiac arrest within the past 30 days etc.; (5) Confirmed or highly suspected acute infectious diseases such as active viral hepatitis active tuberculosis etc.; (6) Those whose skin is broken or infected at the location of acupuncture points; (7) Participated in clinical intervention trials in the past 3 months; (8) Subjects who are considered by the attending physician to be inappropriate to participate in this trial.

研究实施时间:

Study execute time:

From 2024-08-09

To      2025-06-06

征募观察对象时间:

Recruiting time:

From 2024-08-09

To      2025-06-06

干预措施:

Interventions:

组别:

对照组

样本量:

35

Group:

control group

Sample size:

干预措施:

脓毒症常规治疗

干预措施代码:

Intervention:

Conventional treatment of sepsis

Intervention code:

组别:

治疗组

样本量:

35

Group:

Experimental Group

Sample size:

干预措施:

老十针穴位(上脘、中脘、下脘、气海、天枢、内关、足三里);除基础治疗外,还给予电针治疗,每日2次。一名医师每次进行30min的电针治疗:将针插入老十针穴位,确保有得气感觉。针采用鳄鱼针连接。频率为连续波,可耐受对患者的最大电流强度(局部肌肉抽搐或患者可耐受)。

干预措施代码:

Intervention:

Lao Shi zhen acupuncture points (Shangwan ZhongwanXiawan Qihai Tianshu Neiguan Zusanli); In addition to the basic treatment electroacupuncture is given twice a day. 30 minutes of electroacupuncture treatment each time: the needle is inserted into a specific point on the surface of the skin ensuring a feeling of deqi.The frequency is adjusted to a continuous wave which can tolerate the maximum current intensity to the patient

Intervention code:

样本总量 Total sample size : 70

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京中医医院

单位级别:

三甲

Institution/hospital:

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津中医药大学第一附属医院

单位级别:

三甲

Institution/hospital:

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

28天病死率

指标类型:

主要指标

Outcome:

28-day mortality

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝肾功能

指标类型:

副作用指标

Outcome:

Liver and kidney function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

炎症相关指标(WBC、PCT)

指标类型:

次要指标

Outcome:

Inflammation-related markers

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

APACHE Ⅱ评分

指标类型:

次要指标

Outcome:

APACHE II. SCORE

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SOFA评分

指标类型:

次要指标

Outcome:

SOFA score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胃肠功能指标(肠鸣音、AGI 分级)

指标类型:

次要指标

Outcome:

Gastrointestinal function indicators (bowel sounds AGI grade)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

feces

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 90
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

使用Excel 2019软件进行均匀随机分组。按入组顺序得到一列1-70的数据,运用RAND函数随机生成0-1之间的随机数。运用RANK函数将其排列,再除以35,得到0-2之间的数字。再运用ROUNDUP函数进行向上舍入,得到一列1或2的数据。将1赋值为“试验组”,2赋值为“对照组”,完成70个病人的随机分组,记录分组结果。

Randomization Procedure (please state who generates the random number sequence and by what method):

Excel 2019 software was used for uniform randomization. According to the enrollment order a column of data 1-70was obtained and the RAND function was used to randomly generate random numbers between 0-1. The RANK function was used to rank them and then divided by 35 to get a number between 0 and 2. The ROUNDUP function is then used to round up to get a column of 1 or 2 data. The value of 1 was assigned to the "experimental group" and the value of 2 was assigned to the "control group". 70 patients were randomly divided into groups and the grouping results were recorded.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

No

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统